Market cap
₹45 Cr
Recently Viewed
Clear AllBSE: 524602
₹25.15
₹0.30
(1.21%)
As on 06-May-2026IST
Market cap
₹45 Cr
Revenue (TTM)
₹45 Cr
P/E Ratio
113
P/B Ratio
1.8
Div. Yield
0.4 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
₹0 Cr
ROE
8 %
ROCE
8.4 %
Industry P/E
22.93
EV/EBITDA
24.4
Debt to Equity
1.4
Book Value
₹14
EPS
₹0.3
Face value
10
Shares outstanding
17,971,920
CFO
₹-9.62 Cr
EBITDA
₹4.50 Cr
Net Profit
₹-0.14 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Bandaram Pharma
| -15.5 | 0.3 | -7.1 | -35.8 | -- | -- | -- |
|
BSE Commodities
| 8.7 | 14.4 | 5.0 | 19.5 | 18.2 | 12.3 | 16.5 |
|
Company
|
2025
|
2024
|
|---|---|---|
|
Bandaram Pharma
| -34.7 | 48.8 |
|
BSE Small Cap
| -6.6 | 29.0 |
|
BSE Commodities
| 12.5 | 8.1 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Bandaram Pharma
|
25.2 | 45.2 | 45.2 | 0.6 | 3.7 | 3.2 | 113 | 1.8 |
| 68.1 | 1,342.6 | 1,581.6 | 18.8 | -2.7 | 1 | 71.6 | 0.7 | |
| 1,549.7 | 17,316.2 | 407.2 | -101.7 | -104.8 | -8.4 | -- | 4.7 | |
| 376.2 | 6,823.0 | 6,875.2 | 267.9 | 7.3 | 5 | 26.3 | 1.2 | |
| 87.2 | 826.0 | 797.4 | 92.7 | 12.5 | 15.3 | 8.9 | 1.3 | |
| 268.5 | 1,695.3 | 1,621.0 | 75.2 | 3.2 | 4.2 | 20.3 | 0.8 | |
| 247.3 | 4,057.5 | 0.0 | -0.2 | -- | -1.5 | -- | 17.3 | |
| 10.2 | 1,189.9 | 863.6 | 80.7 | 9.2 | 38.5 | 14.9 | 4.2 | |
| 158.6 | 1,098.0 | 4,644.9 | 247.8 | 3.6 | 11.3 | 4.4 | 0.5 | |
| 528.7 | 3,497.3 | 4,088.7 | 147.9 | 2.4 | 4.1 | 24.5 | 1.0 |
No Review & Analysis are available.
Shiva Medicare Limited does not have significant operations. The company was incorporated in 1991 and is based in Hyderabad, India.
Incorporated
1993
Chairman
B Deepak Reddy
Managing Director
B Deepak Reddy
Headquarters
Bengaluru, Karnataka
Website
Looking for more details about Bandaram Pharma Packtech Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The share price of Bandaram Pharma Packtech Ltd is ₹25.15 (BSE) as of 06-May-2026 IST. Bandaram Pharma Packtech Ltd has given a return of -35.84% in the last 1 years.
The P/E ratio of Bandaram Pharma Packtech Ltd is 113.00 times as on 06-May-2026, a 393 premium to its peers’ median range of 22.93 times.
The P/B ratio of Bandaram Pharma Packtech Ltd is 1.80 times as on 06-May-2026, a 96 premium to its peers’ median range of 0.92 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
101.80
|
4.40
|
|
2024
|
85.33
|
3.62
|
|
2023
|
29.56
|
7.13
|
|
2022
|
0.00
|
0.00
|
|
2021
|
0.00
|
0.00
|
The 52-week high and low of Bandaram Pharma Packtech Ltd are Rs 49.70 and Rs 22.00 as of 06-May-2026.
Bandaram Pharma Packtech Ltd has a market capitalisation of ₹ 45 Cr as on 06-May-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Bandaram Pharma Packtech Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.